The effect of adopting new GLI-2012 spirometric reference values on airflow limitation GOLD classification Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015
Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Ventilation heterogeneity in COPD and healthy smokers relates to diffusion capacity, resistance and reactance Source: International Congress 2015 – Monitoring airway diseases with lung function tests Year: 2015
Can we use pre-bronchodilator spirometry to define post-bronchodilator airflow obstruction? Source: International Congress 2015 – Epidemiology of respiratory disease Year: 2015
Airflow reversibility on long term outcomes of patients with COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014
Exercise related desaturation in patients with COPD – Another step towards phenotyping the disease Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Lung function change and exacerbations in patients with COPD in the WISDOM study Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015
Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013
Airway resistances deteriorate following spirometry in asthma and COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Bronchodilation test estimation using spirometry and electrical impedance analysis in bronchial asthma and COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015
The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Flow-volume parameters in COPD related to extended measurements of lung volume, diffusion and resistance Source: Annual Congress 2013 –Lung function tests to monitor airway diseases Year: 2013
Role of the lung volume measurement in the diagnosis of obstructive diseases in patients with restrictive ventilatory impairment Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014
Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016
Heterogeneity inside group D COPD patients: About 827 cases Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
COPD, obesity and non-invasive ventilation Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013
Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013
Impulse-oscillometry (IOS) differences in asthma and COPD patients, and healthy-subjects Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014
FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity Year: 2013